Suppr超能文献

MIB-1抗体对人肿瘤中Ki67的细胞膜反应性:事实还是假象?

Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact?

作者信息

Leonardo Eugenio, Volante Marco, Barbareschi Mattia, Cavazza Alberto, Dei Tos Angelo Paolo, Bussolati Gianni, Papotti Mauro

机构信息

Division of Pathology, San Luigi Hospital, Orbassano, Torino, Italy.

出版信息

Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):220-3. doi: 10.1097/01.pai.0000213122.66096.f0.

Abstract

Ki67 immunohistochemistry is a widely used marker of the tumor proliferative fraction. Apart from the nuclear staining of dividing cells, MIB-1 monoclonal antibody was also found to stain the cell membrane of some tumor types. Indeed, such membrane reactivity was proposed as a diagnostic feature of hyalinizing trabecular tumor (HTT) of the thyroid. To verify the diagnostic role of Ki67 membrane pattern, 6 HTTs, 8 pulmonary sclerosing hemangiomas (SH), and 6 other human tumors with MIB-1 cell membrane immunoreactivity were stained by immunoperoxidase with 5 different anti-Ki67 antibodies in different experimental conditions. We show here that the cell membrane reactivity reported in HTT is produced only by MIB-1 and not by other antibodies to Ki67 (including commercially available mouse and rabbit monoclonal antibodies). In addition, this peculiar pattern is obtained only if the reaction is performed at room temperature, because automated immunostainers which operate at 37 degrees C do not produce any MIB-1 membrane localization. The same findings were obtained in the other 6 tumors. Conversely, sclerosing hemangioma of the lung did not produce any MIB-1 cell membrane reactivity in our hands. A cross-reactivity of the MIB-1 monoclonal antibody with an epitope expressed at the cell membrane level (rather than an artifact) seems the most likely explanation for this finding, because the immunoreactivity is generally intense and uniform in the membrane positive tumors. We conclude that when Ki67 immunohistochemistry is used for diagnostic purposes in a suspected HTT, only MIB-1 clone at room temperature should be employed.

摘要

Ki67免疫组化是一种广泛应用的肿瘤增殖分数标志物。除了对分裂细胞进行核染色外,还发现MIB-1单克隆抗体可对某些肿瘤类型的细胞膜进行染色。事实上,这种膜反应性被认为是甲状腺透明变小梁肿瘤(HTT)的诊断特征。为了验证Ki67膜模式的诊断作用,在不同实验条件下,用5种不同的抗Ki67抗体对6例HTT、8例肺硬化性血管瘤(SH)和6例其他具有MIB-1细胞膜免疫反应性的人类肿瘤进行免疫过氧化物酶染色。我们在此表明,HTT中报道的细胞膜反应性仅由MIB-1产生,而非其他抗Ki67抗体(包括市售的小鼠和兔单克隆抗体)。此外,只有在室温下进行反应才能获得这种特殊模式,因为在37℃运行的自动免疫染色仪不会产生任何MIB-1膜定位。在其他6种肿瘤中也得到了相同的结果。相反,在我们的研究中,肺硬化性血管瘤未产生任何MIB-1细胞膜反应性。MIB-1单克隆抗体与细胞膜水平表达的表位发生交叉反应(而非人为假象)似乎是对此发现最合理的解释,因为在膜阳性肿瘤中免疫反应性通常强烈且均匀。我们得出结论,当在疑似HTT中使用Ki67免疫组化进行诊断时,应仅采用室温下的MIB-1克隆。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验